Related Experiment Videos
Hemorrhagic subependymal giant cell astrocytoma
P Kalina1, K E Drehobl, R W Greenberg
1Department of Radiology, North Shore University Hospital, Manhasset, NY 11030, USA.
Pediatric Radiology
|January 1, 1995
Summary
Tuberous sclerosis patients can develop subependymal giant cell astrocytomas (SEGCA). Hemorrhage into these tumors is exceptionally rare but can occur, as seen in this case.
Area of Science:
- Neurology
- Radiology
- Oncology
Background:
- Tuberous sclerosis is a genetic disorder causing tumors in various organs.
- Subependymal giant cell astrocytomas (SEGCA) are common intracranial tumors in tuberous sclerosis.
- Hemorrhage into SEGCA is an exceedingly rare complication.
Observation:
- A patient with tuberous sclerosis presented with symptoms suggestive of a neurological event.
- Initial imaging revealed a hemorrhagic lesion within the brain.
Findings:
- Computed tomography (CT) and magnetic resonance (MR) imaging confirmed the presence of a hemorrhagic subependymal giant cell astrocytoma (SEGCA).
- The findings were consistent with tuberous sclerosis, a condition known for intracranial manifestations.
- The rarity of hemorrhage within SEGCA was a key diagnostic consideration.
Implications:
- This case highlights the importance of considering rare complications in tuberous sclerosis.
- Accurate CT and MR imaging are crucial for diagnosing SEGCA and its complications.
- Understanding these rare events aids in patient management and prognosis for tuberous sclerosis.